Clinical Trials Directory

Trials / Completed

CompletedNCT01994616

Prospective Evaluation of the Use of Intralesional Cryotherapy for Treatment of Keloid and Hypertrophic Scars

Intralesional Cryotherapy for Treatment of Keloid Scars: a Prospective Evaluation

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Amsterdam UMC, location VUmc · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types.

Detailed description

Intralesional (IL) cryotherapy is a novel treatment for keloids and hypertrophic scars, in which the scar is frozen from inside. Published results are promising, however only Caucasian patient populations have been studied. This prospective evaluation studies the effectiveness of IL cryotherapy in treating keloids and hypertrophic scars in a large population of mixed Fitzpatrick skin types. All patients with keloid or hypertrophic scars meeting inclusion criteria were treated with a liquid nitrogen based device called Cryoshape Scar quality and possible recurrence are assessed pre- and postsurgery (3, 6 and 12 months) with objective devices determine scar color, scar elasticity, scar volume and patient's skin type. In addition, scars are evaluated using the Patient and Observer Scar Assessment Scale.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntralesional cryotherapyIntralesional (IL) cryotherapy is a treatment for keloids and hypertrophic scars, in which the scar is frozen from inside with the use of a cryoneedle

Timeline

Start date
2009-01-01
Primary completion
2011-01-01
Completion
2011-06-01
First posted
2013-11-26
Last updated
2013-11-26

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01994616. Inclusion in this directory is not an endorsement.